News and Events

COMSTECH OIC Internship Participants Visited PT Kalbio Global Medika


COMSTECH OIC is the Committee on Scientific and Technological Cooperation of the Organization of Islamic Cooperation. COMSTECH OIC was established on January 1981. COMSTECH OIC holds the internship program for the students or scholars who are the citizens of OIC member states. This internship program aimed to enhance research and development capacity of OIC member state scientists in the field of virology and vaccine technology.

Regarding to this internship program, all students or scholars joined the preparation meeting from 29 Aug 2022 to 04 Oct 2022 in several cities, including Jakarta, Cikarang, Bandung, and Surabaya. One of the agenda of this preparation meeting is factory visit to several biopharmaceutical manufacturing facilities, including PT Kalbio Global Medika (KGM) at Cikarang which was held on 01 Sep 2022.


During the factory visit, we explained our KGBIO Group Company Profile and KGM Company Profile. Then, they are invited to see our production facilities of API and formulation-filling-and-finish, and our R&D facilities. The visit was accompanied by Director General of Multilateral Cooperation of the Ministry of Foreign Affairs and attended by Director of Sociocultural and OINB, Director of Pharmaceutical Production and Distribution, Director of Operations Bio Farma, Assistant Deputy for Health Industry, Ministry of State Owned Enterprises and Vice Chancellor for Research and Innovation Padjajaran University (UNPAD).


COMSTECH OIC Internship participants were explained of upstream process using bioreactor at KGM during the factory visit. KGM currently has two 50 L Bioreactors and will expand the capacity to 1000 L next year.





KGM at a Glance

Kalbio Global Medika (KGM) is one of the first and the pioneer of biopharmaceuticals in Indonesia, established in 2014 and inaugurated officially in 2018 by the President of the Republic of Indonesia, Ir. Joko Widodo. KGM is part of the Kalbe Group, a subsidiary of PT Kalbe Genexine Biologics (KGbio), which is a clinical-stage biotechnology company focused on bringing biologics medical innovation to markets outside US/Canada, Western Europe, and China. KGM is an Innovative CDMO, equipped with CMC and scale-up capabilities plugged into Boston biotech ecosystem and state-of-the-art facility to enhance efficiency and productivity. With API manufacturing, formulation, fill and finish capabilities of biosimilar and novel biologics, averaging 10 million units of syringes, cartridges, and vials, KGM supplies local and international markets.



OIC COMSTECH Internship Program